Showing results (121-130 of 15,488) with videos related to
Sort By:
Pageof 1,549
International Immunopharmacology|December 3, 2022
Dectin3 protects against hepatocellular carcinoma by regulating glycolysis of macrophagesWei Qu, Shuping Qiao, Ling Liu, et al.International Immunopharmacology|December 3, 2022
Cytokines network in primary membranous nephropathyQihan Zhao, Haoran Dai, Yuehong Hu, et al.International Immunopharmacology|December 3, 2022
Host resistance to Mycoplasma gallisepticum infection is enhanced by inhibiting PI3K/Akt pathway in Andrographolide-treating chickensTengfei Wang, Yufei Xiao, Ronglong Luo, et al.International Immunopharmacology|December 3, 2022
Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficienciesZhaoyang Li, Kristin Follman, Ed Freshwater, et al.International Immunopharmacology|December 3, 2022
m(6)A methyltransferase METTL3 relieves cognitive impairment of hyperuricemia mice via inactivating MyD88/NF-κB pathway mediated NLRP3-ASC-Caspase1 inflammasomeYanfang Chen, Peng Cao, Zijian Xiao, et al.International Immunopharmacology|December 3, 2022
Interaction of aging and Immunosenescence: New therapeutic targets of agingShuxian Liao, Qian Ning, Yao Chen, et al.International Immunopharmacology|December 3, 2022
Chloroquine treatment influences immunologicalmemory through the PD-1/PD-L1 pathway during the initiation of Plasmodium chabaudi infectionChuanyang Peng, Danni Li, Li Zheng, et al.International Immunopharmacology|December 3, 2022
Epoxymicheliolide prevents dextran sulfate sodium-induced colitis in mice by inhibiting TAK1-NF-κB pathway and activating Keap1-NRF2 signaling in macrophagesJinchen He, Lu Liu, Xiaojun Liu, et al.International Immunopharmacology|December 3, 2022
Ginsenoside compound K increases glucagon-like peptide-1 release and L-cell abundance in db/db mice through TGR5/YAP signalingFengyuan Tian, Wangda Xu, Lan Chen, et al.International Immunopharmacology|December 3, 2022
Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK/ERK/S100A4 signalling pathwayWenting Yang, Lin Pan, Yiju Cheng, et al.Pageof 1,549